ArticleClinical pharmacology and therapeutics2026

Model-Based Patient Selection and Dosing Strategies for HRAS and PIK3CA Dysregulated HNSCC: A QSP Model for Alpelisib and Tipifarnib Combination.

Jaehee Shim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.